Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for acute myocardial infarction) trial

Journal of the American College of Cardiology

Volumn 60, Issue 5, 2012, Pages 381-387

  Hofma, Sjoerd H ^a   Brouwer, Jan ^a   Velders, Matthijs A ^a   Van'T Hof, Arnoud W J ^b   Smits, Pieter C ^c   Queré, Michel ^a   De Vries, Cornelis Jan ^a   Van Boven, Adrianus J ^a  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c Maasstad Hospital Rotterdam ^*  (Netherlands)

Author keywords

acute myocardial infarction; drug eluting stent; percutaneous coronary intervention; stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYPHER; EVEROLIMUS; HEPARIN; RAPAMYCIN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CAUSE OF DEATH; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; SIROLIMUS; SURVIVAL RATE;

EID: 84864241157     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.01.073     Document Type: Article

References (32)

1. G.W. Stone, S.G. Ellis, D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
2. A. Caixeta, M.B. Leon, A.J. Lansky 5-year clinical outcomes after sirolimus-eluting stent implantation J Am Coll Cardiol 54 2009 894 902
3. A. Kastrati, J. Mehilli, J. Pache Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039 (Pubitemid 46376803)
4. B. Lagerqvist, S.K. James, U. Stenestrand, J. Lindback, T. Nilsson, L. Wallentin Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden N Engl J Med 356 2007 1009 1019 (Pubitemid 46376801)
5. J. Daemen, P. Wenaweser, K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice Lancet 369 2007 667 678 (Pubitemid 46281313)
6. J. Kotani, M. Awata, S. Nanto Incomplete neointimal coverage of sirolimus-eluting stents Angioscopic findings J Am Coll Cardiol 47 2006 2108 2111
7. M. Joner, G. Nakazawa, A.V. Finn Endothelial cell recovery between comparator polymer-based drug-eluting stents J Am Coll Cardiol 52 2008 333 342 (Pubitemid 352001347)
8. S.H. Hofma, W.J. van der Giessen, B.M. van Dalen Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation Eur Heart J 27 2006 166 170 (Pubitemid 43069032)
9. P.A. Lemos, F. Saia, S.H. Hofma Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction J Am Coll Cardiol 43 2004 704 708 (Pubitemid 38229548)
10. C. Spaulding, P. Henry, E. Teiger Sirolimus-eluting versus uncoated stents in acute myocardial infarction N Engl J Med 355 2006 1093 1104 (Pubitemid 44394916)
11. R. Violini, C. Musto, F. De Felice Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-elevation myocardial infarction: 3 year results of the SESAMI trial J Am Coll Cardiol 55 2010 810 814
12. G.W. Stone, A.J. Lansky, S.J. Pocock Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
13. E. Kedhi, K. Sheik Joesoef, E. McFadden Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
14. G.W. Stone, A. Rizvi, W. Newman Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
15. D.E. Cutlip, S. Windecker, R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
16. G.J. Laarman, M.J. Suttorp, M.T. Dirksen Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention N Engl J Med 355 2006 1105 1113 (Pubitemid 44394917)
17. P.J. Vlaar, T. Svilaas, I.C. van der Horst Cardiac death and re-infarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study Lancet 371 2008 1915 1920 (Pubitemid 351778190)
18. D. Arzamendi, H. Quoc, J.F. Tanquay Effect on bleeding, time to revascularization, and one-year clinical outcomes of the radial approach during primary PCI in patients with STEMI Am J Cardiol 106 2010 148 154
19. S.S. Jolly, S. Yusuf, J. Cairns Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL) Lancet 377 2011 1409 1420
20. M.S. Chen, J.M. John, D.P. Chew Bare metal stent restenosis is not a benign clinical entity Am Heart J 151 2006 1260 1264 (Pubitemid 43866610)
21. G.D. Dangas, A. Caixeta, R. Mehran Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction Circulation 123 2011 1745 1756
22. J. Obata, Y. Kitta, H. Takano Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction J Am Coll Cardiol 50 2007 1305 1309 (Pubitemid 47446093)
23. L. Mauri, T.S. Silbaugh, P. Garg Drug-eluting or bare-metal stents for acute myocardial infarction N Engl J Med 359 2008 1330 1342
24. S.S. Brar, M.B. Leon, G.W. Stone Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis J Am Coll Cardiol 53 2009 1677 1689
25. L. Räber, S. Windecker Primary percutaneous coronary intervention and risk of stent thrombosis A look beyond the HORIZON Circulation 123 2011 1709 1712
26. M.I. Hamilos, M. Ostojic, B. Beleslin Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion J Am Coll Cardiol 51 2008 2123 2129 (Pubitemid 351721001)
27. S. Silber, S. Windecker, P. Vranckx Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial Lancet 377 2011 1241 1247
28. L. Räber, P. Jüni, E. Nüesch Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization J Am Coll Cardiol 57 2011 2143 2151
29. P.C. Smits, E. Kedhi, K. Royaards Two year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice J Am Coll Cardiol 58 2011 11 18
30. E. Kedhi, M. Gomes, K. Sheik Joesoef Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial EuroIntervention 7 2012 1376 1385
31. S.M. Snapinn Non-inferiority trials; commentary Curr Control Trials Cardiovasc Med 1 2000 19 21
32. EMEA Points to consider on switching between superiority and non-inferiority http://www.tga.gov.au/pdf/euguide/ewp048299en.pdf Accessed July 27, 2011